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Dynamic Modeling of Nonmedical Opioid Initiation: Epidemic and Access
Alexandra Nielsen BS, Portland State University, Teresa D. Schmidt MS, Portland State University, Dennis McCarty PhD, Oregon Health and Science University, Wayne Wakeland PhD, Portland State University
We report development of a systems level dynamic model of initiation and nonmedical use of pharmaceutical opioids in the US. The
model calibrated to 1995-2005 National Survey of Drug Use and
Health (NSDUH) data, predicts 2006-2011 data well. Preliminary findings indicate that interventions which reduce the perceived attractiveness of opioids for recreational use may be able to reduce initiation and nonmedical use most significantly, while supply restriction
effected through drug take back days and prescribing changes may
have more modest effects. We argue that system dynamics is an
effective approach for evaluating potential interventions to this complex system where the use of pharmaceutical opioids to treat pain is
fraught with undesirable distal outcomes.

High Demand
People with use
disorders
have
high demand for
free opioids.

Local Free
Supply

Over time some recreational users develop use disorders.

Supply
Running Out

Demand

The number of overdose deaths involving opioids tripled between
1999 and 2006 in the US, rising to 14,800 in 2008 (Warner et al.
2011). As evidenced by the high fraction of opioid overdose decedents without prescriptions (Hall et al. 2008), nonmedical use of
pharmaceutical opioids plays a significant role in the prevalence of
overdose deaths. Leftover opioid prescriptions are likely involved in
much of this diversion (Compton and Volkow 2006). Studies suggest
that there is a large reservoir of unused opioids stored in homes
(Bates et al. 2011; Gilson 2012), and the high fraction of individuals
receiving drugs for free from friends and family as reported in the
NSDUH (SAMHSA 2012) is likely to be strongly correlated with the
size of this reservoir.

People with use disorders may exhaust
the local free supply.

Transition to Paying
When a person with a use disorder exhausts her
local free supply, she begins paying for opioids.

Infection
Susceptible nonusers
initiate opioid use
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Total Nonmedical Users

To initiate drug use a susceptible person
must have access to opioids.

Intervention: Reduce % Willing to Share
Total Nonmedical Users

Access

Methods

Discussion
The relative impact of the three interventions simulated can not be
explained by feedback alone as all three interventions are amplified
by positive feedback loops. The infectivity intervention reduces the
initiate rate by 25%, and this reduction is immediately amplified by
feedback. The willingness to share intervention impacts both the infection loop and the global availability loop, but the 25% reduction is
indirect. Reducing by 25% the number of people who are willing to
share prescriptions only reduces the likelihood that a potential initiator will know at least one prescription holder by a small percentage.
This likelihood is based on a binomial distribution and is large when a
large fraction of the population has prescriptions. So the impact on
initiation and global supply is much smaller than 25%. This smaller
reduction is amplified by positive feedback, which suggests that limiting sharing is an intervention with leverage. Supply reduction
through prescription take back days is the least effective strategy primarily because the reservoir of leftover medicines is so large that the
reduction implemented did not cause the system to be supply constrained.
Conclusion
The current model offers a formalized model of a common pathway
to nonmedical opioid initiation and provides a tool for comparing
the impact of multiple policy interventions. System dynamics modeling brings insights on the global dynamics of nonmedical opioid
use and can be used to inform policy interventions to ameliorate
the associated public health problems.

Infectivity
The idea of using opioids is
infectious and spreads from
recreational users to nonusers.
Higher infectivity,
more initiation.
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Results
The model contains 5 state variables, 13 exogenous parameter variables, 21 endogenous (calculated) parameters and 10 rates of change.
Three principal feedback loops (a peer initiation epidemic loop, a
global availability loop, and a personal accessibility loop) contribute
to the nonlinear growth patterns in nonmedical opioid initiation and
use. Peer initiation is modeled as the infection of a susceptible population by peers. Global availability of opioids for nonmedical use depends on the number of current opioid users and how much free
leftover medicine they obtain from prescription holders. When availability diminishes, reduced personal accessibility requires transitions

High users only
have free access to
a fraction of global
supply, through
their own family
and friends.

Use Disorders

Background

Drawing from empirical data and a panel of experts, a system dynamics simulation was developed to reproduce historical trends in
nonmedical use of pharmaceutical opioids in the United States. Data to support assumptions and model parameters were drawn from
publicly available sources in the literature. Data on initiation and
nonmedical use were obtained from the NSDUH for the years 1995
to 2011. System dynamics is a simulation method in which complex
relationships and feedback loops are specified and mathematically
formalized. The resultant set of differential equations was calibrated to replicate opioid use data from 1995-2005, used to predict behavior from 2006 to 2011, and to evaluate policy interventions.

to paying for opioids. Compelling susceptible non-users to resist initiation (e.g. Gosin et al. 2003) was more effective in reducing nonmedical use than compelling prescription holders not to share their medicines (e.g. FDA 2013), and reducing global availability through prescription take back events (e.g. DEA 2012).

Contact
A susceptible person makes contact with infectious
people at a given rate.
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A 25% decrease
in the infectivity
of opioid use results in a dramatic decrease
in the number
of nonmedical
users. This is
largely due to

positive feedback.
Lower initiation —> Fewer recreational users —>
Fewer contacts with nonusers —> Lower initiation.
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Nonmedical Users = 3.76%
Initiates = 6.13%
Use Disorder = 3.47%
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